Emerging IV Therapy Research Though more large-scale, randomized clinical trials are needed, a growing body of research supports the use of IV nutrient therapy in cancer care: A phase I/II study demonstrated that IV vitamin C was safe and well-tolerated in combination with chemotherapy for pancreatic cancer
Distribution of homocysteine between competing pathways
Increased levels of ROS and lipid peroxidation products and/or decreased levels of antioxidant enzymes, such as superoxide dismutase (SOD) and catalase, and antioxidant compounds, such as glutathione, have been reported in both NAFLD/NASH patients as well as a variety of animal models of NAFLD 9,10,11,12,13,14
Stacking BPC-157 With Other Peptides BPC-157 + TB-500 Goal: Accelerate healing and flexibility Protocol: BPC-157 250500 mcg daily (local injection) TB-500 25 mg weekly (divided doses) These two peptides complement each other: BPC-157 targets the injured tissue, while TB-500 promotes systemic healing
19 BraunerR.RappaportR.PrevotC.CzernichowP.ZuckerJ